Raymond James Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$640K Buy
29,679
+1,396
+5% +$30.1K ﹤0.01% 3836
2025
Q1
$470K Sell
28,283
-7,878
-22% -$131K ﹤0.01% 3942
2024
Q4
$664K Buy
+36,161
New +$664K ﹤0.01% 3706